LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 80.31 | 27.76 | 560 | 6976 | 0.0803 | 0.4576 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 29.19 | 27.76 | 1436 | 1863 | 0.7707 | 0.9160 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 57.18 | 84.90 | 4269 | 6963 | 0.6131 | 0.8519 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 30.90 | 27.76 | 45 | 2032 | 0.0221 | 0.0811 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 55.48 | 84.90 | 80 | 6567 | 0.0122 | -0.0094 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 82.01 | 27.76 | 916 | 7000 | 0.1309 | 0.5500 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 30.90 | 27.76 | 1545 | 2032 | 0.7602 | 0.9134 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 9.47 | 84.90 | 891 | 447 | 1.9914 | 1.6656 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 82.01 | 27.76 | 5993 | 7000 | 0.8561 | 0.9614 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 11.18 | 84.90 | 960 | 492 | 1.9498 | 1.6025 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 85.42 | 27.76 | 1395 | 7025 | 0.1986 | 0.6334 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 57.18 | 84.90 | 83 | 6963 | 0.0119 | -0.0035 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 85.42 | 27.76 | 6418 | 7025 | 0.9135 | 0.9775 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 55.48 | 84.90 | 4136 | 6567 | 0.6297 | 0.8579 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 88.84 | 27.76 | 6822 | 6965 | 0.9795 | 0.9948 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 12.88 | 84.90 | 1045 | 531 | 1.9680 | 1.5834 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 87.13 | 27.76 | 1242 | 6987 | 0.1777 | 0.6105 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 12.88 | 84.90 | 4 | 531 | 0.0075 | -0.6850 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 34.30 | 27.76 | 1737 | 2449 | 0.7090 | 0.8964 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 62.29 | 84.90 | 4673 | 7934 | 0.5890 | 0.8446 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 88.84 | 27.76 | 1302 | 6965 | 0.1869 | 0.6205 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 17.99 | 84.90 | 1163 | 898 | 1.2937 | 1.1571 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 34.30 | 27.76 | 55 | 2449 | 0.0225 | 0.1116 | MN20160318_Q01 | C14 |